20.2ª.09 BIBLIOGRAFIA.

  
   Libros.
  • Andrews JC, Honrubia V. Meniere´s disease. En: Balow RW u cols (Eds). Disorders of the Vestibular sustem. Nueva York/Oxford Unversity Press 1996;300-317.
  • Committee on Hearing and Equilibrium. Ménière's disease: Criteria for diagnosis and evaluation of therapy for reporting. Trans Amer Acad Ophth Otolaryngol 1972;76:1462–4.
  • Committee on Hearing and Equilibrium. Ménière's disease: Criteria for diagnosis and evaluation of therapy for reporting. AAO-HNS Bulletin 1985;5:6–7.
  • Patrick Locatelli. Le vertige périphérique invalidant. Concept, traitement et résultats. A propos de 140 observations. Thèse Médicale. Marseille 1994.
  • Ruckenstein MJ, Harrison RV. Cochlear pathology in Menière's disease. P., editors. Menière's Disease. The Hague, The Netherlands: Kugler Publications, 1999:195-202.
 
   Capítulo 1.   Introducción e historia.
  • Antonio SM, Friedman R. Meniere’s Disease. In: Jackler RK, Brackmann DE, eds. Neurotology. Philadelphia: Elsevier; 2005:621–638.
  • Beasley NJ, Jones NS. Ménière's disease: evolution of a definition. J Laryngol Otol 1996; 110: 1107-13. [Pub-Med]
  • Birch C.A. Meniere's disease. Prosper Meniere (1799-1862).Practitioner. 1974;213(1275):391-2.
  • Birdsall HH. Meniere's disease. Laryngoscope 1991;101(8):915.
  • Drachman D A, Hart C W. An approach to the dizzy patient. Neurology 1972;22:323. [Medline]
  • Dida Dederding. Clinical and Experimental Examiniations in Patients suffering from Morbus Menièri, including a Study of the Problem of Bone Conduction. Acta Oto-Laryngologica, 1929; Supplementa 8: 369.
  • Flourens P. Recherches expérimentales sur les propriétés et les functions du système nerveux dans les animaux vertébrés. Paris, France: Crevot; 1824.
  • Hallpike CS, Wright J. On the histological changes in the temporal bone of a case of Meniere's disease. Proc R Soc Med 1939;32:1646-1652.
  • Itard JMG. Traité des maladies de l'oreille et de l'audition. Vols 1 and 2. Paris, France: Méquignon-Marvis; 1821.
  • Jay V. Prosper Meniere. Arch Pathol Lab Med. 2000;124 (2): 192-3. [Pub-Med]
  • Jay V. On a historical note: Meniere's disease. J Insur Med. 2005;37(4):330-2.
  • Hamann K, Arnold W. Meniere's disease. Adv Otorhinolaryngol 1999;55:137-68.
  • McBride P, James A.  Epilepsy, vertigo and ear disease. Edinburgh Med J, 1880;25: 702-08.
  • Menière P. Mémoire sur des lésions de l´oreille interne donnant lieu à des symptòmes de congestion cérèbrale apoplectiforme. Gaz Med Paris 1861;16:597-601.
  • Mollison WM. A brief survey of the history or the mastoid operation. J Laryngol Otol 1930;45:95-101.
  • Morrison AW. Prosper Meniere (1799-1862). A synopsis of his life and times.Ear Nose Throat J. 1997;76(9):626-31.
  • Paparella MM, Mancini F. Vestibular Menière's disease. Otolaryngol Head Neck Surg 1985;93(2):148-51.
  • Robert W Baloh. Prosper Ménière and His Disease. Arch Neurol. 2001;58:1151-1156.
  • Sajjadi H, & Paparella, MM. Meniere's disease. Lancet, 2008;372, 406–414.
  • Thorp MA, James AL. Prosper Meniere. Lancet. 2005;17;366(9503):2137-9.
  • Thorp MA, James AL. Prosper Ménière. The Lancet, 2006;366(9503): 2137-2139. [Pub-Med]
  • Trousseau A. De la congestion cérébrale apoplectiforme, dans ses rapports avec épilepsie. Gaz Med Paris. 1861;16:51.
  • Watanabe I. Incidence of Meniere's disease, including some other epidemiological data. In: Oosterveld, W J, editor(s). Meniere's disease: A comprehensive appraisal. Chichester: John Wiley & Sons Ltd, 1983:9-23.
 
   Capítulo 2.   Fisiopatología, etiopatogenía y epidemiología.
  • Alleman AM, Dornhoffer JL, Arenberg IK, Walker PD. Demonstration of autoantibodies to the endolymphatic sac in Meniere’s disease. Laryngoscope 1997;107:211–215.
  • Altman F, Fowler EP. Histological fidings in Meniere´s symptom complex. Ann Otol Rhinol Laryngol 1943;52:52.
  • Altman F, Zechner G. The pathology and pathognesis of endolymphatic hidrops. Arch Ohren Nasen Kehlkopfhielkd 1968;192:1.
  • Andrews JC, Honrubia V. Vestibular function in experimental endolymphatic hydrops. Laryngoscope 1988; 98: 479-85.
  • Antoli-Candela F. This histopathology of Meniere's disease. Acta Otolaryngol , (suppl 340), 1976;1-42.
  • Arslan M. Modificartions of the osmotic pressure of perilymph and endolymph. An hypothesis on the pathogenesis of Ménière´s disease. Acta Otolaryng 1969;67:360-377.
  • Arslan M. A new hypothesis on the plurifactorial etiology of Meniere's disease. Acta Otolaryngol Suppl. 1977;357:1-19.
  • Atlas MD, Chai F, Boscato L. Meniere's disease: evidence of an immune process. Am J Otol. 1998;19(5):628-31.
  • Birgenson L, Gustavson KH, Stahle J. Familial Méniere´s disease a genetic investigation. Am J Otol 1987;8:323-326.
  • Brookes GB. Circulating immune complexes in Meniere’s disease. Arch Otolaryngol Head Neck Surg 1986;112:536–540.
  • Coker NJ, Coker RR, Jenkins HA, Vincent KR. Psychological profile of patients with Menière’s disease. Arch Otolaryngol Head Neck Surg 1989;115:1355–1357.
  • Cruijsen van N, Dullaart RP, Wit HP, Albers FW. Analysis of cortisol and other stress-related hormones in patients with Ménière’s disease. Otol Neurotol 2005;26:1214–1219.
  • Densert B. Effects of oberpressure on the hearing function in Meniere´s disease. Acta otolaryngol 1986;102:32-42.
  • Derebery MJ et al. Enfermedad de Ménière: una enfermedad autoinmune. Laryngoscope 1991;101:225-229.
  • Derebery MJ. Allergic and immunologic aspects of Meniere's disease. Otolaryngol Head Neck Surg. 1996;114:360-5.
  • Derebery MJ. The role of allergy in Meniere’s disease. Otolaryngol Clin North Am 1997;30:1007–1016.
  • Dornhoffer JL, Waner M, Arenberg IK, Montague D. Immunoperoxidase study of the endolymphatic sac in Menière’s disease. Laryngoscope 1993;103:1027–1034.
  • Duke WW. Meniere syndrome caused by allergy. JAMA 1923; 21:79-81.
  • Elwood S, Carlton JH, Cliffe MJ. A psychological contribution to the management of Ménière’s disease. Practitioner 1982;226:1149–1152.
  • Evans KL, Baldwin DL, Bainbridge D, Morrison AW. Immune status is patients with Ménière’s disease. Arch Otorhinolaryngol 1988;245:287–292.
  • García Ibañez E, García Ibáñez JL, Iurato S. Estructura submicroscópica del ganglio vestibular humano en la enfermedad de Ménière. Anales O.R.L. Iber-Amer 1977; IV, 1-2:49-54.
  • Halama AR. The etiopathogenesis of Meniere's disease. Ear Nose Throat J. 1987;66(3):107-11.
  • Hallpike C, Cairns H. Observations on the pathology of Menière’s syndrome. Journal of Laryngology and Otology 1938;53:625-55.
  • Kitahara M, Takeda T, Yazawa Y, Matsubara H, Kitano H. Experimental study on Meniere's disease. Otolaryngol Head Neck Surg. 1982;90(4):470-81.
  • Klar J, Frykholm C, Friberg U, Dahl N. A Meniere's disease gene linked to chromosome 12p12.3. Am J Med Genet B Neuropsychiatr Genet. 2006;141(5):463-7.
  • Lim JS, Lange ME, Megerian CA. Serum antidiuretic hormone levels in patients with unilateral Meniere’s disease. Laryngoscope 2003;113:1321–1326.
  • Masaya Takumida, Akinobu Kakigi, Taizo Takeda, Matti Anniko. Ménière's disease: A long-term follow-up study of bilateral hearing levels. Acta Oto-Laryngologica 2006;126: 921-925.
  • Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops. Otol Neurotol 2005;26:74–81.
  • Moffat DA, Booth JB, Morrison AW. Investigación metabólica en la enfermedad de Ménière. Hallazgos preliminares. The Journal of laringology and Otology 1979;93:545-561.
  • Morales Angulo C, Gómez Castellanos J, Bezos Capelastegui JT, Carrera F. Epidemiología de la enfermedad de Meniere en Cantabria. Acta Otorrinolaring Esp 2003;54:601-605.
  • Morse GG, House JW. Changes in Ménière’s disease responses as a function of the menstrual cycle. Nurs Res 2001;50:286–292.
  • Paparella MM, de Sousa LC, Mancini F. Meniere's syndrome and otitis media. Laryngoscope. 1983;93:1408-15.
  • Paparella MM. Pathology of Meniere's disease. Ann Otol Rhinol Laryngol Suppl. 1984;112:31-5.
  • Paparella MM. Pathogenesis of Meniere's disease and Meniere's syndrome. Acta Otolaryngol Suppl. 1984;406:10-25.
  • Paparella MM, Kimberley BP. Pathogenesis of Meniere's disease. J Vestib Res. 1990-91;1(1):3-7.
  • Pérez Garriges H, Llopis V, Morera C. A psicosocial study of Menière´s disease. En: Long term results and indications in otology and otoneurosurgery. Proceedings of the Politzer Society Conference. Kugler publ. Amsterdam, 1990.
  • Pulec J L: Meniere's disease: Results of a 2.5 year study of the etiology, natural history and results of treatment. Laryngoscope 1972;82:1703. [Medline]
  • Pulec JL. The discovery of the pathogenesis of Meniere's disease. Ear Nose Throat J. 1995;74(8):510-1.
  • Ruckenstein MJ. Immunologic aspects of Meniere's disease. Am J Otolaryngol 1999;20:161-5. [Medline]
  • Schmidt PH, Brunsting RC, Antvelink JB.. Meniere's disease: etiology and natural history. Acta Otolaryngol. 1979;87(3-4):410-2. [Medline]
  • Schmidt PH. Pathophysiology of the Meniere attack: facts and theories. Acta Otolaryngol. 1983;95(5-6):417-20.
  • Schuknecht HF. Meniere's disease, pathogenesis and pathology. Am J Otolaryngol. 1982;3(5):349-52.
  • Schuknecht HF. The pathophysiology of Meniere's disease. Am J Otol. 1984;5(6):526-7.
  • Semman MT, Alagraman KN, Megerian CA,  The basic sciencie of Méniere´s disease and endolymphatic  hydrops. Curr Opin Otolarynol Head Neck Surg 2005;13:301-307.
  • Stahle J,Wilbrand HF. The temporal bone in patients with Menière's disease. Acta Otolaryngol (Stockh) 1983;95:81-94.
  • Stahl e J,Stahle C,Arenberg IK. Icidence of Méniére s disease. Arch Otolaryngol 1978;104:99-12.
  • Takeda T, Kakigi A, Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl 1995; 519:219–222.
  • Takeda T, Takeda S, Kitano H, Okada T, Kakigi A. Endolymphatic hydrops induced by chronic administration vasopressin. Hear Res 2000;140:1–6.
  • Tiran BA et al. Maladie de Ménière. Encyclo. Med. Chir. (Paris-France) Otorhino-Laryngologie, 20-205 A10, 4-1989; 1-18.
  • Tomoda K, Suzuka Y, Iwai H, Yamashita T, Kumazawa T. Meniere's disease and autoimmunity: clinical study and survey. Acta Otolaryngol Suppl. 1993;500:31-4.
  • Waele de C, Huy PT, Diard JP, Freyss G, Vidal PP. Saccular dysfunction in Meniere's disease. Am J Otol. 1999 Mar;20(2):223-32. [Pub-Med]
  • Williams LL, Lowery HW, Shannon BT. Evidence of persistent viral infection in Meniere's disease. Arch Otolaryngol Head Neck Surg. 1987;113(4):397-400. [Medline]
  • Wilson WH. Antigenic excitation in Meniere's disease. Laryngoscope. 1972;82(9):1726-35.
  • Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT: Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984;94(8):1098-102. [Medline].
  • Yoo TJ. Etiopathogenesis of Meniere's disease: a hypothesis. Ann Otol Rhinol Laryngol Suppl. 1984;113:6-12. [Medline]
  • Yilmazer C. Relationship of the cochlear aqueduct and inner ear pressure in Meniere's disease and in a normal population. Otol Neurotol 22: 534-538, 2001.
  • Yoshino K, Ohashi T, Urushibata T, Kenmochi M, Akagi M. Antibodies to type II collagen and immune complexes in Menière’s disease. Acta Otolaryngol Suppl 1996;522:79–85.
  • Yoo TJ. Etiopathogenesis of Meniere's disease: a hypothesis. Ann Otol Rhinol Laryngol Suppl. 1984;113:6-12. [Medline]
 
  Capítulo 3.   Clínica y pruebas complementarias.
  • Alleman AM, Dornhoffer JL, Arenberg IK, Walker PD.  Laryngoscope. 1997;107(2):211-5. [Medline]
  • Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere´s disease. Acta otolaryngol 2000;120:480-3.
  • Daumann R, Aran JM, Portmann M. Summating potencial and water balance in Meniere´sdisease. Ann Otol Rhinol laryngol 1986;95:389-95.
  • Douglas RA. Meniere's disease, serum cholesterol levels and atheroma. Med J Aust. 1966;25;1(26):1104-8.
  • Enander A, Stahle J. Hearing in Meniere's disease. A study of pure-tone audiograms in 334 patients. Acta Otolaryngol 1967;64:543-556.
  • Filipo R, Barbara M. Natural history of Meniere´s disease: stating the patients for their symptoms? Acta Otolaryngol (Stockh) Suppl 1997;526:10-13.
  • Gibson WPR. The role of electrocochleography in the understanding of the pathophysiology of Menire´s disease. Auris Nasus Larynx 1996; 23(suppl 1):12-17.
  • Hof-Duin NJ, Wit HP. Evaluation of low-frequency biasing as a diagnostic tool in Menière patients. Hear Res. 2007;231(1-2):84-9. [Pub-Med]
  • Huang TS, Lin CC: Delayed endolymphatic hydrops: Study and review of clinical implications and surgical treatment. ENT Ear Nose Throat J 2001;80:76-91.
  • Infante Sánchez JC, Allue San José JL. Nuestra experiencia con el gycerol test en el hidrops laberíntico. Acta Otolaringol Esp 1976;27:95-104.
  • Klockhoff I, U. Endolymphatic hydrops revealed by glicerol test. Preliminaire report. Acta Oto-Laryng (Stockh) 1966;5:459-462.
  • Nakagawa H, Watanabe Y, Mizukoshi K, Ohi H. Plain radiological findings in Meniere's disease. Auris Nasus Larynx 1994;21(3):137-42.
  • Olaizola F, Tapia MC, Murúa JJ. Evoluación electronistagmográfica de la enfermedad de ménière. Acta Otolaringol Esp 1981;32(3): 353-359.
  • Pérez N, et al. Dissimilarities in auditory and vestibular function in Menière´s disease. En: Ars B (ed) Inner ear partition. The hague, Kugler Publ, 1988;51-65.
  • Powers WH. Metabolic aspects of Meniere's disease. Laryngoscope. 1972;82(9):1716-25.
  • Selmani Z, Pyykko I, Ishizaki H, Ashammakhi N. Use of electrocochleography for assessing endolymphatic hydrops in patients with Lyme disease and Meniere's disease. Acta Otolaryngol. 2002;122(2):173-8.
  • Tomoda K, Suzuka Y, Iwai H, et al. Menière’s disease and autoimmunity: clinical study and survey. Acta Otolaryngol Suppl 1993;500:31–34.
  • Waele de C, Huy PT, Diard JP, Freyss G, Vidal PP. Saccular dysfunction in Ménière's disease. Am J Otol. 1999;20(2):223-32.
  • Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Síntomas, ansiedad y hándicap en los pacientes vertiginosos: desarrollo de una valoración del síntoma vértigo. J Psychol Res 1992;36:731-741.
  • Yen PT, Lin CC, Huang TS. A preliminary report on the correlation of vestibular Meniere's disease with electrocochleography and glycerol test. Acta Otolaryngol Suppl. 1995;520 Pt 2:241-6. [Medline].
 
   Capítulo 4.   Diagnóstico, diagnóstico diferencial y evolución.
  • Balon RW, Jacobson K, Winder T. Drop attacks with Meniere´s syndrome. Ann Neurol 1990;28:384-387.
  •  Balow RW. Neurotology of migraine. Headache 1997;37:615-621.
  •  Black FL, Effron MZ, Burns DS. Diagnosis and management of drop attacks of vestibular origin: Tumarkin´s otolithic crises. J Otolaryngol Head Neck Surgery 1982;90:256-262.
  • Brandt T. Otolithic Vertigo. Advances in Ororhinolaryngology, 2001;58:34-47. [Pub-Med]
  • Charachon R, Gratacap B, Barthez M, Benoit-Gonin F. Natural history of Meniere's disease concerning 92 cases from 1971 to 1980. Rev Laryngol Otol Rhinol (Bord ) 1989; 110(5):453-456.
  • Cutrer FM, Balow RW. Migraine-associated dizziness. Headache 1992;32:300-304.
  • Friberg U, Stahle J, Svedberg A. The natural course of Menière's disease. Acta Otolaryngologica 1984;406(Supplement):72-77.
  • Friberg U, Stahle J, Svedberg A. The natural course of Meniere's disease. Acta Otolaryngol Suppl 1984; 406:72-77.
  • Harold F, Schuknecht, et alt. Hidrops endolinfático retardado y su relación con el vértigo de Ménière. Ann. Otol. Rhinol. Laryngol. 1990;99.
  • Haye R, Quist-Hanssen S. The natural course of Meniere's disease. Acta Otolaryngol 1976;82:289-293.
  • Ishiyama G, Ishiyama A, jacobson K, Baloh W. Drop attacks in older patients secondary to an otologic cause. Neurology 2001;57:1103-1104.
  • Ishiyama G, Ishiyama A, Baloh W. Drop attacks and vertigo secondary to a non-Meniere otologic cause. Arch Neurol 2003;60:71-75..
  • Janzen VD, Russel RD. Conservative management of Tumarkin´s otolhitic crises. J Otolaryngol 1988;17:359-361.
  • Kentala E, Havia M, Pyykkö I. Short-lasting drop attacks in Meniere´s disease. Otolaryngol Head Neck Surg 2001;124:526-530.
  • Lee H, López I, Ishiyama A, Balow RW. Can migrain damage the inner ear? Arch Neurol 2000;57:1631-1634.
  • Liston SL, Paparella MM, Mancini F, Anderson JH. Otosclerosis and endolymphatic hydrops. Laryngoscope 1984;94(8):1003-7.
  • Ödkvist LN, Bergenius J. Drop attacks in Meniere´s disease. Acta Otolaryngol suppl (Stockh) 1988;55:82-85.
  • Oku R, Shigeno K, Kumagami H, Takahashi H. Otolith dysfunction during vertiginous attacks in Meniere's disease. Acta Otolaryngol 2003;123(9):1035-9. [Medline]
  • Passali D, Damiani V, Mora R, Passali FM, Passali GC, Bellussi L. P0 antigen detection in sudden hearing loss and Meniere's disease: a new diagnostic marker? Acta Otolaryngol. 2004;124(10):1145-8. [Medline
  • Pillsbury HC, Potsma, DS. Lermoyez's syndrome and the otolithic crisis of Tumarkin. Otolaryngological Clinics of North America, 1983;90(2):256-262.
  • Pérez Fernandez N, Pérez-Garrigues H, Antolí Candela F. Enfermedad de Menière: Criterios diagnósticos, criterios para establecer estadios y normas para la evaluación de tratamientos. Revisión bibliográfica y actualización. Acta Otorrinolaringol Esp 2002; 53:427-430.
  • Pulec J L: Meniere's disease: Etiology, natural history, and results of treatment. Otolaryngol. Clin. North Am 1973;6:25. [Medline]
  • Pulec J L: Meniere's disease: Results of a 2.5 year study of the etiology, natural history and results of treatment. Laryngoscope 1972;82: 1703. [Medline] 
  • Radtke A, Lempert L, Gresty MA, Broojes GB, Bronstein AM. Migraine and Ménière's disease. Is there a link?  Neurology 2002;59:1700-1704.
  • Rasseck CH, Harcker LA. The prevalence of Migraine in Ménière disease. Laryngoscope 1992;102:135-138.
  • Schuknecht HF, Gulya AJ. Endolymphatic hydrops, an overview and classification. Ann Otol Rhinol Laryngol 1983;106(suppl):1–20.
  • Timmer FC, Zhou G, Guinan JJ, Kujawa SG, Herrmann BS, Rauch SD. Vestibular evoked myogenic potential (VEMP) in patients with Meniere's disease with drop attacks. Laryngoscope 2006;116(5):776-779.
  • Tumarkin A. The otolithic catastrophe. BMJ 1936;2:175-177.
 
       Capítulo 5.   Tratamiento médico.
  • Altman F, Waltner JG. Ultrasonic therapy of Meniere's disease. Evol Psychiatr (Paris). 1961;40:607-9.
  • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18:350-4.
  • Bjorne A, Agerberg G. Symptom relief after treatment of temporomandibular and cervical spine disorders in patients with Ménière’s disease: a three-year follow-up. Cranio 2003;21:50–60.
  • Bolignano D, Coppolino G, Criseo M, Campo S, Romeo A, Buemi M. Aquaretic agents: what’s beyond the treatment of hyponatremia? Curr Pharm Des 2007;13:865–871.
  • Burcon MT. Parkinson’s disease, Meniere’s syndrome, trigeminal neuralgia and Bell’s palsy: one cause, one correction. Dynamic Chiropractic 2003;21:41–44,48.
  • Claes J, Van de Heyning PH. Medical treatment of Meniere's disease: a review of literature. Acta Otolaryngol Suppl. 1997;526:37-42. [Medline]
  •  Claes J, Van de Heyning PH. A review of medical treatment for Meniere's disease. Acta Otolaryngol Suppl. 2000;544:34-9. [Medline]
  • Cooksey FS. Rehabilitation and vestibular injuries. Proc Royal Soc Med 1946;39:273.
  • Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl. 2000;544:27-33. [Medline]
  • Corvera J, Corvera G. Long-term effects of acetazolamide on the hearing loss of Méniére s disease. Am J Otol 1989; 10:142 45.
  • Deelen vanGW, Huizing EH. Use of a diuretic (Dyazide) in the treatment of Menière’s disease. A double-blind crossover placebo-controlled study. ORL J Otolaryngol Relat Spec 1986;48:287–292.
  • Densert B, Densert O, Erlandsson B, Sheppard H. Transmission of complex pressure waves through the perilymphatic fluid in cats. Acta Otolaryngol 1986;102:403–409.
  • Densert O, Carlborg B, Stagg J. Transmission of a low frequency pressure steps to the perilymphatic fluid. Acta Otolaryngol 1981;91:55–64.
  • Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280:1569–1575.
  • Feenstra L. The management of tinnitus with or without Menière’s disease. Acta Otolaryngol Suppl 1997;526: 47–49.
  • Franz B, van der Laan F. P-100 in the treatment of Ménière’s disease: a clinical study. Int Tinnitus J 2005;11: 146–149.
  • Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R. Betahistine dihydrochloride versus flunarizine. A doubleblind study on recurrent vertigo with or without cochlearsyndrome typical of Menière’s disease. Acta Otolarynngol Suppl 1991;490:1–10.
  • Fursternberg AC, Lashmet HT, Lathrop FD. Ménière’s symptom complex: medical management. Ann Otolaryngol Rhinol Laryngol 1934;43:1035–1047.
  • Gates GA, Green JD Jr, Tucci DL, Telian SA. The effect of transtympanic micropressure treatment in people with unilateral Meniere’s disease. Arch Otolaryngol Head Neck Surg 2004;130:718–725.
  • Gates G, Verrall A, Green JD Jr, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006;132:1311–1316.
  • Gottshall KR, Hoffer ME, Moore RJ, Balough BJ. The role of vestibular therapy in the treatment of Meniere’s disease. Otolaryngol Head Neck Surg 2005;133:326–328.
  • Hain TC, Fuller L, Weil L, Kotsias J. Effects of T’ai Chi on balance. Arch Otolaryngol Head Neck Surg 1999;125: 1191–1195.
  • Hesse G, Schaaf H, Kolbe U, Brehmer D, Andres R. The prescription of hearing aids in Meniere patients. In: Sterkers O, Ferrary E, Dauman R, Sauvage JP, Tran Ba Huy P, eds. Ménière’s Disease 1999 – Update. The Hague, The Netherlands: Kugler Publications, 1999:681–683.
  • Heyning Van de PH, Wuyts F, Boudewyns A. Surgical treatment of Meniere's disease. Curr Opin Neurol. 2005;18(1):23-8. [Medline]
  • Itoh A, Sakata E. Tratamiento de las alteraciones vestibulares. Acta Otolaryngol (Stockh), 1991; suppl:481:617-623.
  • Jackson CG, Glasscock ME, Davis WE, et al. Medical management of Meniere's disease. Ann Otol Rhinol Laryngol 1981; 90(2 Pt 1): 142-7[Medline].
  • James A, Thorp M. Menieres´s disease. Clinical Evidence 2001;348-355.
  • James AL, Burton MJ. Betahistine for Meniere´s disease or syndrome (Cochrane review). En: The Cochrane Library, 3, 2001.Oxford: Update Software.
  • Kemink JL. et al. Estimulación eléctrica de l sistema auditivo tras laberintectomía. The American Journal of Otology 1991:12-1. 
  • Klockhoff I, Lindblom U. Menière’s disease and hydrochlorothiazide (Dichlotride)–a critical analysis of symptoms and therapeutic effects. Acta Otolaryngol 1967;63:347–365.
  • Kilpatrick JK, Sismanis A, Spencer RF, Wise CM. Low-dose oral methotrexate management of patients with bilateral Ménière’s disease. Ear Nose Throat J 2000;79:82–92.
  • Klockhoff I, Lindblom U, Stahle J. Diuretic treatment of Meniere disease. Long-term results with chlorthalidone. Arch Otolaryngol 1974;100:262–265.
  • Knox GW, McPherson A. Menière's disease: differential diagnosis and treatment. Am Fam Physician 1977;55(4):1185-90, 1193-4. 
  • Lassen LF, Hirsch BE, Kamerer DB. Utilización de nimodipino en el tratamiento médico de la enfermedad de Ménière: experiencia clínica. Am J Otol 1996; 17:577-580.
  • Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol 1972;305(Suppl):29–46.
  • Naganuma H, Kawahara K, Tokumasu K, Okamoto M. Water may cure patients with Meniere disease. Laryngoscope 2006;116:1455–1460.
  • Odkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: a clinical multicentre placebo-controlled study. Acta Otolaryngol Suppl 2000;543:99–101.
  • Rahman MU, Poe DS, Choi HK. Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol 2001;22: 619–624.
  • Ricci V, Sittoni V, Nicora M. Efficacy and safety of betahistine hydrochloride versus placebo in Ménière’s disease. Rivista Italiana Ornitologia Audiologia Foniatria 1987;7: 347–350.
  • Ruckenstein M.J. y al. The treatmen of Meniere's disese: Torok revisited. Laryngoscope 1991;101: 211-218.
  • Thomsen J, Sass K, Odkvist L, Arlinger S. Local overpressure treatment reduces vestibular symptoms in patients with Meniere’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005;26:68–73.
  • Timmerman H. Pharmacotherapy of vertigo: any news to be expected? Acta Otolaryngol Suppl 1994;512:28–32.
  • Thorp MA, Shehab ZP, Bance ML, Rutka JA. Does evidence-based medicina exist in the treatment of Meniere´s disease? A critical review of the last decade of publications. Clinical Otolaryngol 2000;25(6): 456-460.
  • Thirlwall AS, Kundu S. Diuretics for Ménière’s disease or syndrome. Cochrane Database of Syst Rev 2006;3: CD003599.
  • Thai-Van H, Bounaix MJ, Fraysse B. Menière’s disease: pathophysiology and treatment. Drugs 2001;61:1089–1102.
  • Salami A, Dellepiane M, Tinelle E, Jankowska B. Double blind study of betahistine and placebo in the treatment of Ménière’s syndrome [in Italian]. Il Valsalva 1984;60:302–312.
  • Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect of Menière’s disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg 1993;109:680–689.
  • Schmith PF. Pharmacology of the vestibular system. Curr Opin Neurol. 2000;13(1):31-7. [Medline]
  • Schmidt JT, Huizing EH. The clinical drug trial in Menière’s disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl 1992;497:1–189.
  • Siebenhaar F, Ku¨hn W, Zuberbier T, Maurer M. Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. J Allergy Clin Immunol 2007;120: 213–215.
  • Simonton KM. Meniere's disease and the medical treatment of vertigo. Mayo Clin Proc. 1969;44(2):81-4.
  • Steinberger A, Pansini M. The treatment of Meniere’s disease by acupuncture. Am J Chin Med 1983;11:102–105.
  • Storper IS, Spitzer JB, Scanlan M. Use of glycopyrrolate in the treatment of Meniere’s disease. Laryngoscope 1998; 108:1442–1445.
  • Vernon J. Conservative treatment of tinnitus in Menière's disease. Am J Otol, 1988;9(3):201-2.
 
     Capítulo 6.   Tratamientos intratimpánicos.
  • Adair RA, Kerr AG. Streptomycin perfusion of the labyrinth in the treatment of Meniere's disease: a modified technique. Clin Otolaryngol Allied Sci 1999;24:55-57.
  • Arriaga MA, Goldman S. Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998;108:1682–1685.
  • Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 1999;20:357-363.
  • Bagger-Sjöback D, Lundman I, NIlsson-Ehle I. Ciprofloxacin and the inner ear. A morphological and round window membrane permeability study. ORL 1992;54:5-9.
  • Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004;114: 1910–1914.
  • Beck C, Schmidt CL. 10 years of experience with intratympanically applied streptomycin (gentamycin) inthe therapy of Morbus Meniere. Arch Otorhinolaryngol 1978;28;221:149-52.
  • Beck C. Intraympanic apaplication of gentamycin for treatment of Meniere disease. Keig J Med 1986;35:36-41.
  • Beer De L, Stokroos R, Kingma H. Intratympanic gentamicina for intractable Ménière’s disease. Acta Otolaryngol 2007;127:605–612.
  • Black FO, Pesznecker SC. Vestibular ototoxicity. Clinical considerations. Otolaryngol Clin North Am 1993;26: 713–716.
  • Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière’s disease: a meta-analysis. Laryngoscope 2004;114:2085–2091.
  • Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison and use of facilitation agents. Otolaryngol Head Neck Surg 2000;122:521–528.
  • Charabi S, Thomsen J Tos M. round window gentamicin mu-catheter- a new therapeutic tool in Meniere´s disease. Acta Otolaryngol Suppl 2000;543:108-110.
  • Darrouzet V, Erre JP, Dulon D, Camicas van Gout M, Aran JM, Putout PA, Negrevergne M, Dauman R, Bebear JP. Données de l´impedanciométrie mulfréquentielle dans les phalogies cochéaires. Aproche experiméntale che le chichila et le cobaye. Rev Laryngol Otol Rhinol 2000;120:23-00.
  • Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004;25:1034–1039.
  • Fowler EP. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948;52:239-301.
  • Fowler EP Jr, Feind CR. Toxicity of streptomycin for the auditory and vestibular mechanisms. Am Rev Tuberc 1949;60:39–44.
  • Gates GA: Innovar treatment for Meniere's disease. Acta Otolaryngol (Stockh) 1999;119:189-93. [Medline]
  • Gottshall KR, Hoffer ME, Kopke RD. Vestibular rehabilitation after low dose microcatheter administered gentamicina treatment for Ménière’s disease. In: Proceedings of the 4th International Symposium on Ménière’s Disease. The Hague, The Netherlands: Kuglar Publications, 2000: 663–668.
  • Hanson HV. The treatment of endolymphatic hidrops (Menierés disease) with streptomycin. Ann Otol Rhinol Laryngol 1951;60:675-692.
  • Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Ménière’s syndrome. Otol Neurotol 2001;22:210–214.
  • Hirsch BE, Kamerer DB. Role of chemical labyrinthectomy in the treatment of Meniere’s disease. Otolaryngol Clin North Am 1997;30:1039–1049.
  • Hirvonen TP, Peltomaa M, Ylikoski J. Intratympanic and systemic dexamethasone for Ménière’s disease. ORL J Otorhinolaryngol Relat Spec 2000;62:117–120.
  • Hone SW, Nedzelski J, Chen J. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation? J Otolaryngol 2000;29(2):83-7. [Medline]
  • Huag TS. Three new surgeries for treatment of intractable Meniere´s disease. Am J Otol 1999;20:233-237.
  • Iee Ching Wu, MD; Lloyd B. Minor, MD Long-Term Hearing Outcome in Patients Receiving Intratympanic Gentamicin for Ménière's Disease. Laryngoscope 2003;113:815-820.
  • Ikeda K, Morizono T. Effect of ototopic application of a corticosteroid preparation on cochelar funtion. ann Otol 1991;12:150-153.
  • Ishiyama G, Lopez I, Baloh RW, Ishiyama A. Histopathology of the vestibular end organs after intratympanic gentamicina failure for Meniere’s disease, Acta Otolaryngol 2007;127:34–40.
  • Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P. Low dose transtympanic gentamicin treatment for intractable Ménière’s disease: a prospective study. J Med Assoc Thai 2007;90:327–334.
  • Kelly RM, Meyer JD, Matsuura JE, Shefter E, Hart MJ, Malone DJ, Manning MC. In vitro release kinetics of gentamicin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Indust Pharmacy 1999;25:15-20.
  • Kyösti Laítakiri. Gentamicina intratimpánica en la enfermedad de Ménière severa. Clin. Otolaryngol 1990;15:545-548.
  • Langman A.W., Kimin J.L. y Graham M.D. Tratamiento progresivo con estreptomicina para la enfermedad de Ménière bilateral. Ann. Otol. Rhinol. Laryngol 1990;99: 923-926.
  • Magnan J, Chays A. Chirurgie functionelle du pédicule acoustico-facial. Rev Laryngol Otol Rhinol 1998;119:151-154.
  • Marzo, S et al: Introtympanic Theropy lor persistent vertigo alter endolymphatic sac surgery. Otolaryngol Head and neck surgery 2002; 126:31-33.
  • Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-219.
  • Montandon P, Guillemin P, Hausler R. Prevention of vertigo in Meniere´s syndrome by means of transtympanic ventilation tubes. ORL K Otorhinolaryngol Relat Spec 1988;50:377-81.
  • Parnes SM, Spektor A, Strominger N. Effects of lidocaine infusion in cats after unilateral labyrinthectomy. Arch Otolaryngol Head Neck Surg, 1988;144: 653-656. [Medline]
  • Peterson WM, Isaacson JE. Current management of Ménière’s disease in an only hearing ear. Otol Neurotol 2007;28:696–699.
  • Pyykko I, Ishizaki H, Kaasinen S: Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 1994;110:162-7. [Medline]
  • Pyykko I, Eklund S, Ishizaki H, Aalto H. Postural compensation after intratympanic gentamicin treatment of Meniere's disease. J Vest Res 1999;9:19-26.
  • Rosenberg S, Silverstein H, Flanzer J, Wanamaker H. Bilateral Meniere's disease in surgical versus nonsurgical patients. Am J Otol 1991;12;336-340.
  • Schmidt PH, Brunsting RC, Antvelink JB. Meniere's disease: etiology and natural history. Acta Otolaryngol 1979; 87(3-4):410-412.
  • Schuknecht HF. Ablation therapy in the mangment of Menierés disease. Laringoscope 1956;66:859-870▪    Schuknecht HF. Ablation therapy in the managment of Menierés disease. Acta Otolaryngol (Stock) 1957;132:3-42.
  • Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere's-associated sudden sensorineural hearing loss. Otol Neurotol. 2005;26(5):890-5.
  • Sennaroglu L, Dini FM, Sennaroglu G, Gursel B, Ozkan S. Transtympanic dexamethasone application in Meniere's disease: an alternative treatment for intractable vertigo. J Laryng Otol 1999;113:217-221.
  • Sennaroglu, L., G. Sennaroglu, B. Gursel, et al. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg 2001;125(5):537-43. [Medline]
  • Silverstein H, Norrel H. Retrolabyrinthine vestibular neurectomy. Otolarhyngol Head Neck Surg 1982;90:788-782.
  • Shea JJ Jr, Ge X: Streptomycin perfusion of the labyrinth through the round window plus intravenous streptomycin. Otolaryngol Clin North Am 1994;27:317-24. [Medline]
  • Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: a prospective, randomized, doubleblind, crossover trial. Am J Otol 1998;19:196–201.
  • Silverstein H. The MicroWick™ to deliver medication to the inner ear. Ear Nose Throat J 1999;78:595-600.
  • Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999;120:649-655.
  • Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meneire's disease: preliminary comparison of two regimens. J Otolaryngol 1995;24:340-344. 11.
  • Yamazaki T, et al. Introtympanic gentamicin theropy lar Menieres disease placed by tubal catheter with sistemyc isosorbide. Arch Otorhinolaringol1988;245: 170-174. 
  • Yetiser S, Kertmen M, Yildirim A. Vestibular diuresis in suspected Meniere patients. Acta Otorhinolaryngol Belg 2004;58:119–123.
  • Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Síntomas, ansiedad y hándicap en los pacientes vertiginosos: desarrollo de una valoración del síntoma vértigo. J Psychol Res 1992;36: 731-741.
  • Youssef TF, et al. Intratympanic gentamicin injection for the treatment of Meniere’s disease. Am J Otol. 1998;19(4):435-42.
  • Waele De C, Tran Ba Huy P, Diard JP, Freyss G, Vidal PP. Sacular dysfuntion in Meniere´s patients. A vestibular-evoked myogenic potencial study. Ann N Y Acad Sct 1999;28:871:392-7.
  • Waele de C, R. Meguenni R, G. Freyss G, F. Zamith F, N. Bellalimat N, Vidal PP, et al. Intratympanic gentamicin injections for Meniere disease: vestibular hair cell impairment and regeneration. Neurology  2002;59:1442–1444.  
 
   Capítulo 7.   Tratamiento quirúrgico.
  • Cohen H. et al. Invalidez en la enfermedad de Ménière. Arch. Otolaryngol. Head Neck Surg.; 1995, 121: 29-33.
  • Committee on Hearing and Equilibrium: Report of Subcommittee on Equilibrium and its Measurement. Meniere's disease: criteria for diagnosis and evaluation of therapy for reporting. Trans Am Acad Ophthalmol Otolaryngol 1972 Nov-Dec.
  • Commitee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for diagnosis and evaluation of therapy in Meniere´s disease. Otolaryngol Head Neck Surg 1995;113:181-185.
  • Gianoli GJ, Larouere MJ, Kartush JM: Sac-vein decompression for intractable Meniere's disease: two-year treatment results. Otolaryngol Head Neck Surg 1998;118:22-9. [Medline]
  • Gibson WP. The effect of surgical removal of the extraosseous portion of the endolynphatic sac in patients suffering from Meniere´sdisease. J Laryngol Otol 1996;110:1008-11.
  • Glasscock ME 3d, Jackson CG, Poe DS: What I think of sac surgery in 1989. Am J Otol 1989;10:230-3. [Medline]
  • House WF: Subarachnoid shunt for drainage of endolymphatic hydrops. Laryngoscope 1962;72:713-29.
  • Honrubia V., Bell TS., Harris MR., Baloh RW, Fisher LM. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol 1996;17: 595 – 602.
  • Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head NeckSurg 1990;116:424–7.
  • Jack Wazen, M.D. et al. Hearing after retrolabyrinthine Vestibular Neurectomie. Laryngoscope 1990;100:477-480.
  • Kinney SE., Sandridge SA. and Newman. CW. Long-term effects of Meniere’s Disease on hearing and quality of life. Am J Otol 1997;18 : 67 – 73.
  • Launois R., Reboul-Marty J, Henry B. Construction and validation of quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Quality of Life Research 1996;5:539-554.
  • Matsuoka I, Kurata K, Nishida Y, Ogata T, Iwasaki S, Ishizaki H. Effects of endolymphatic mastoid shunt operation for patients with Meniere's disease. Acta Otolaryngol (Stockh) 1989;suppl 486:105-116.
  • Mègnigbêto CA, Sauvage JP, Launois R. Validation clinique d´une échelle du vertige: EEV (European Evaluation of Vertigo) Rev Laryngol Otol Rhinol 2001;122:95-102.
  • Monsell EM, Wiet RJ: Endolymphatic sac surgery: methods of study and results. Am J Otol 1988;9:396-402. [Medline]
  • Paparella MM, Sajjadi H: Endolymphatic sac enhancement: Principles of diagnosis and treatment. Am J Otol 1987;8:294-300.
  • Pappas DG, Pappas DG. Vestibular nerve section: long-term follow-up. Laryngoscope 1997;107:39.
  •  Portmann G: The saccus endolymphaticus and an operation for draining the same for the relief of vertigo. Arch Otolaryngol 1927; 6:309.
  • Semaan MT, Alagramam KN, Megerian CA. The basic science of Meniere’s disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg 2005;13:301–307.
  • Söderman AC, Bergenius J, Bagger-Sjöbäck D, Tjell C, Langius A. Patients’ subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière’s disease. Otol Neurotol 2001;22: 526–533.
  • Shea JJ Jr: Classification of Meniere's disease. Am J Otol 1993;14:224-9. [Medline] 
  • Schuknecht HF,Gulya AJ. Endolymphatic hydrops. An overview and classification. Ann Otol Rhinol Laryngol 1997; Suppl 183 ;106: 20.
  • Shea JJ Jr: Classification of Meniere's disease. Am J Otol 1993;14:224-9. [Medline] 
  • Thorp MA, Shehab ZP, Bance ML, Rutka JA. The AAO-HNS Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease: have they been applied in the published literature of the last decade? Clin Otolaryngol Allied Sci 2003;28:173–176.
  • Welling DB, Pasha R, Roth LJ, Barin K. The effect of endolymphatic sac excision in Meniere disease.Am J Otol. 1996;17(2):278-82. [Medline]
  • Yardley L, Verschuur C, Masson E, Luxon L, Haacke N. Somatic and psychological factors contributing tohandicap in people with vertigo. Br J Audiol 1992;26:283 – 290.
 
  Capítulo 8.   Clasificación y estadiaje.
  • Bretlau P, Thomsen J, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease: a three-year follow-up study of patients in a double blind placebo controlled study on endolymphatic sac shunt surgery. Am J Otol. 1984;5(6):558-61. [Medline]                                                                       
  • Bretlau P, Thomsen J, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol. 1989;10(4):259-61. [Medline]
  •  Durland WF Jr, Pyle GM, Connor NP. Endolymphatic sac decompression as a treatment for Meniere's disease. Laryngoscope. 2005;115(8):1454-7. [Medline]
  • James A, Thorp M. Menieres´s disease. Clinical Evidence 2001;348-355.
  • Rosenberg S, Silverstein H, Flanzer J, Wanamaker H. Bilateral Meniere's disease in surgical versus nonsurgical patients. Am J Otol 1991;12;336-340.
  • Thomsen J, Kerr A, Bretlau P, Olsson J, Tos M. Endolymphatic sac surgery: why we do not do it. The non-specific effect of sac surgery. Clin Otolaryngol Allied Sci. 1996;21(3):208-11. [Medline]
  • Thomsen J, Bretlau P, Tos M, Johnsen NJ. Endolymphatic sac-mastoid shunt surgery. A nonspecific treatment modality? Ann Otol Rhinol Laryngol. 1986;95:32-5. [Medline]
  • Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease: three-year follow-up.Otolaryngol Head Neck Surg. 1983;91(2):183-6. [Medline]
  • Thomsen J., Brethan P.,  Tos M., Johnsen NJ.: Placebo effect in surgery forr Menière's disease. A double-blind placebo controlled study on endolynphatic sac shunt surgery. Arc Otolaryngol 1881;107:271-277.
  • Silverstein H, Jones R, Rosenberg S. Transmeatal cochleovestibular neurectomy. In Operative Techniques in Otolaryngology-Head and Neck Surgery: Surgical Manage-ment of Meniere's Disease. Philadelphia, W.B. Saunders, 1991;2:32-34.
  • Silverstein H, Norrell H, Smouha E, Jones R. Combined retrolab-retrosigmoid vestibular neurectomy. An evolution in approach. Am J Otol 1989;10:166-169.
  • Silverstein H, Smouha E, Jones R. Natural history versus surgery for Menière’s disease. Otolaryngology - Head and Neck Surgery 1989;100:6-16.